New Republic Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Buy |
3,876
+62
| +2% | +$11.5K | 0.25% | 55 |
|
|
2025
Q1 | $799K | Buy |
3,814
+120
| +3% | +$25.1K | 0.35% | 47 |
|
|
2024
Q4 | $656K | Sell |
3,694
-23
| -0.6% | -$4.09K | 0.43% | 48 |
|
|
2024
Q3 | $734K | Buy |
3,717
+78
| +2% | +$15.4K | 0.42% | 50 |
|
|
2024
Q2 | $624K | Buy |
3,639
+26
| +0.7% | +$4.46K | 0.31% | 62 |
|
|
2024
Q1 | $658K | Buy |
3,613
+79
| +2% | +$14.4K | 0.42% | 53 |
|
|
2023
Q4 | $548K | Buy |
3,534
+810
| +30% | +$126K | 0.39% | 58 |
|
|
2023
Q3 | $406K | Sell |
2,724
-185
| -6% | -$27.6K | 0.33% | 69 |
|
|
2023
Q2 | $392K | Sell |
2,909
-147
| -5% | -$19.8K | 0.27% | 74 |
|
|
2023
Q1 | $487K | Buy |
3,056
+1,116
| +58% | +$178K | 0.37% | 56 |
|
|
2022
Q4 | $314K | Buy |
+1,940
| New | +$314K | 0.25% | 77 |
|